23andMe gets $200 million in funding to bring its genetic testing to the masses
Getty Images/Kimberly White
23andMe, the DNA testing company that turns saliva into in-depth genetic analysis, is raising $200 million in funding led by Sequoia Capital, sources close to the situation confirmed to Business Insider.
This puts the company at a pre-money valuation of $1.5 billion, according to Axios.
The funding round — first reported by TechCrunch — is the company's first since 2015, when 23andMe raised $115 million at a reported $1.1 billion valuation.
... Читать дальше...